1. Home
  2. KROS vs MNRO Comparison

KROS vs MNRO Comparison

Compare KROS & MNRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KROS
  • MNRO
  • Stock Information
  • Founded
  • KROS 2015
  • MNRO 1957
  • Country
  • KROS United States
  • MNRO United States
  • Employees
  • KROS N/A
  • MNRO N/A
  • Industry
  • KROS Biotechnology: Pharmaceutical Preparations
  • MNRO Automotive Aftermarket
  • Sector
  • KROS Health Care
  • MNRO Consumer Discretionary
  • Exchange
  • KROS Nasdaq
  • MNRO Nasdaq
  • Market Cap
  • KROS 565.0M
  • MNRO 473.8M
  • IPO Year
  • KROS 2020
  • MNRO 1991
  • Fundamental
  • Price
  • KROS $14.52
  • MNRO $15.54
  • Analyst Decision
  • KROS Buy
  • MNRO Buy
  • Analyst Count
  • KROS 14
  • MNRO 4
  • Target Price
  • KROS $20.56
  • MNRO $20.75
  • AVG Volume (30 Days)
  • KROS 413.8K
  • MNRO 1.1M
  • Earning Date
  • KROS 08-06-2025
  • MNRO 07-30-2025
  • Dividend Yield
  • KROS N/A
  • MNRO 7.21%
  • EPS Growth
  • KROS N/A
  • MNRO N/A
  • EPS
  • KROS 0.47
  • MNRO N/A
  • Revenue
  • KROS $232,844,000.00
  • MNRO $1,203,187,000.00
  • Revenue This Year
  • KROS $5,390.70
  • MNRO $1.31
  • Revenue Next Year
  • KROS N/A
  • MNRO $2.56
  • P/E Ratio
  • KROS $31.11
  • MNRO N/A
  • Revenue Growth
  • KROS 85820.30
  • MNRO N/A
  • 52 Week Low
  • KROS $9.12
  • MNRO $12.20
  • 52 Week High
  • KROS $72.37
  • MNRO $30.18
  • Technical
  • Relative Strength Index (RSI)
  • KROS 56.39
  • MNRO 51.18
  • Support Level
  • KROS $13.78
  • MNRO $14.87
  • Resistance Level
  • KROS $14.67
  • MNRO $16.45
  • Average True Range (ATR)
  • KROS 0.45
  • MNRO 1.13
  • MACD
  • KROS 0.03
  • MNRO 0.07
  • Stochastic Oscillator
  • KROS 82.76
  • MNRO 66.80

About KROS Keros Therapeutics Inc.

Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.

About MNRO Monro Inc.

Monro Inc is an operator of retail tire and automotive repair stores in the United States. The company offers replacement tires and tire related services, automotive undercar repair services, and a broad range of routine maintenance services, on passenger cars, light trucks, and vans. It also provides other products and services for brakes; mufflers and exhaust systems; and steering, drive train, suspension, and wheel alignment.

Share on Social Networks: